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Introduction
Fibrosing mediastinitis (FM) is a rare disease of slowly
progressive fibrosis that encases major mediastinal
structures. Complications include obstruction of
mediastinal vasculature, including main pulmonary
arteries, which may lead to life-threatening
hemodynamic compromise. In North America, the
disease is usually a sequela of histoplasmosis. Because
Histoplasma capsulatum (H. capsulatum) is found in the
Ohio River Valley, physicians in Pennsylvania must be
able to recognize and diagnose the disease.

Case Presentation
The patient is a 59 year-old female who was seen for
follow-up in April 2013. She originally presented to the
outpatient office in 2008 with chronic chest pain and
shortness of breath. At that time her chest pain was
constant, stabbing, non-pleuritic, located over the right
anterior chest wall with radiation to the back, and was

relieved with narcotic pain medications. She also had
dyspnea on exertion. She described these symptoms
as having been present for two years and noted that
they had been getting progressively worse. On review
of symptoms, she also noted light headedness with
standing, occasional palpitations, and a dry cough. She
denied weight loss, fevers, chills, hemoptysis, or lower
extremity edema.
Her past medical history was significant for a pulmonary
embolism at the age of 18, treated with warfarin, multiple
episodes of pneumonia from 1999 to 2007, and a
diagnosis of superior vena cava (SVC) syndrome in 2008.
Her social history was significant for a 10 pack year history
of cigarette smoking. Her family history was significant for
her father with myocardial infarction at age 50.
On her most recent physical exam her vitals were
temperature 99.1°F, blood pressure 110/82 mm Hg, pulse

Figure 1: SVC occlusion with dense calcification suggestive of

Figure 2. Calcified granuloma. Ground glass opacity of right

chronic inflammatory or post-radiation etiology

upper lung. Loss of volume of right upper lung
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SVC syndrome was diagnosed in 2008
when she presented to her primary
care provider with left neck swelling.
CT of her neck at the time showed a
heterogeneous density in the left external
jugular vein which was thought to be a
thrombus; however, upper and lower
extremity Dopplers were negative for
acute thrombus. Further evaluation with
CT of her chest with contrast showed
SVC occlusion with dense calcification,
suggestive of chronic inflammatory or
post-radiation etiology (Figure 1). The
patient, however, denied any history of
radiation exposure or central vein catheterization. Interestingly, the CT of the chest
Figure 3: A. Narrow SVC B. Calcified mediastinal lymph node C. Dilated azygous vein. also showed a chronic calcified occlusion
of the right upper lung (RUL) pulmonary
artery. She also had RUL ground-glass opacities with a
of 72 beats per minute, and oxygen saturation of 97%
calcified granuloma (Figure 2), and calcified mediastinal
on room air. She was without cervical lymphadenopathy
and hilar nodes, prominent venous collateral formation
and lacked neck or face swelling. Her lungs were clear
in the chest wall and mediastinum, and calcifications of
to auscultation, and auscultation of her heart revealed
her spleen (Figures 3,4).
regular rate and rhythm and normal heart sounds with
no murmurs, rubs or gallops. There was no cyanosis,
clubbing or edema of the extremities. Her skin exam was
notable for prominent veins of the upper chest wall and
Differential Diagnosis
dilated tortuous abdominal wall veins.
Bronchoscopy performed to further evaluate her
abnormal CT findings in her lungs was largely
unrevealing. Tissue biopsy was negative for
malignancy and sputum stained negative for acid-fastbacilli (AFB). Fungal, AFB and respiratory viral cultures
were also negative. Rheumatologic workup, including
antinuclear antibody (ANA), perinuclear anti-neutrophil
cytoplasmic antibodies (p-ANCA), cytoplasmic-ANCA
(c-ANCA), and rheumatoid factor (RF) were negative.
Given the CT imaging which showed calcified
mediastinal lymph nodes and calcified occlusions
of the SVC and RUL pulmonary artery, as well as
thick fibrotic tissue in the mediastinum, the patient
was diagnosed with fibrosing mediastinitis (FM). FM
is a radiologic diagnosis. Etiologies in North America
include histoplasmosis (82%), idiopathic (18%), and
Mycobacterium tuberculosis or other mycoses.1

Figure 4: A. Dilated chest wall collaterals. B. Calcified SVC and
hilar lymph node. C. Splenic calcifications.
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Outcome and Follow-up
The patient is followed annually for her fibrosing
mediastinitis. The latest CT thorax performed in 2012
showed ground-glass opacities and loss of volume
in the RUL with traction bronchiectasis. She also had
new narrowing of the right superior pulmonary vein in
addition to the chronic occlusion of the RUL pulmonary
artery. Her imaging also showed dilated azygous and
hemiazygous veins and extensive anterior chest wall
venous collaterals that have increased in diameter over
the last three years.

Discussion
Fibrosing mediastinitis (FM) is a chronic form of
mediastinitis that is characterized by invasive fibrosis
that compresses and encases mediastinal structures,
including lymph nodes, central vessels, and airways. FM
is diagnosed by radiological findings of calcifications
of hilar and mediastinal lymph nodes and evidence
of fibrotic tissue within the mediastinum. While the
pathophysiology of fibrosing mediastinitis is poorly
understood, it is believed that most cases in North
America are due to Histoplasma capsulatum.1 About
80% of patients with FM present with radiographic
or serologic evidence of Histoplasmosis infection
or exposure.2 Rare case reports have also described
fibrosing mediastinitis secondary to tuberculosis and
other fungal infections, including blastomycosis,
coccidiomycosis and aspergillosis. 3 In about 18% of
patients, no infectious cause is identified and the
etiology is thus labeled as idiopathic. Other conditions
that mimic the radiological findings of FM include
sarcoidosis, mesothelioma, idiopathic retroperitoneal
fibrosis, and radiation-associated mediastinal fibrosis.
The most likely etiology of this patient’s FM is
histoplasmosis, as she presented with radiological
evidence of prior histoplasmosis infection, including
the characteristic mediastinal granuloma and splenic
calcifications. She is also from an area endemic to
H. capsulatum. It is likely that her FM was secondary
to histoplasmosis even in spite of her urine antigen
testing for histoplasmosis being negative, as only
~10% of patients with chronic lesions have positive
antigen testing, and patients with chronic forms of
histoplasmosis such as FM generally do not have
positive urine antigen testing.1 The urine antigen testing
is most useful in acute pulmonary histoplasmosis with
large inoculum or disseminated histoplasmosis.

H. capsulatum is endemic to the Ohio and Mississippi
River Valleys with several microfoci in Mid-Atlantic
States, Africa, Southeast Asia, and Europe. The
dimorphic fungus exists as a mold in the soil and as
a yeast at 37°C. Nitrogen-rich soil from bird and bat
excrement enhances the growth of H. capsulatum.
The mold is easily aerosolized and inhaled. Once in
the lungs it is phagocytized by macrophages. 4 The
severity of illness depends on the amount of inoculum
and host immune response. Over 80% of young adults
from the Ohio and Mississippi River Valleys have been
exposed, as evidenced by positive skin antigen testing.
In most cases, patients have no symptoms or a very
mild pneumonia-like illness that resolves on its own
within four weeks. Acute exposure to a large amount
of inoculum or severe immunosuppression can result
in severe pneumonitis and respiratory failure.5
While most symptomatic infections with H. capsulatum
have acute pulmonary manifestations, ~1% of patients
have extra-pulmonary manifestations, including
pericarditis, rheumatologic syndromes (arteritis,
erythema nodosum), mediastinal lymphadenitis,
progressive disseminated histoplasmosis, and
mediastinal fibrosis.5
Mediastinal fibrosis is a rare complication of Histoplasma
infection, and it is not known why <1% of patients
exposed to the mold develop FM.6 One widely accepted
hypothesis for the pathophysiology includes leakage of
fungal antigen from the infected lymph nodes in the
mediastinal space resulting in a delayed hypersensitivity
reaction.7 Another hypothesis proposes that rupture
of a caseous lymph node from a primary infection
invokes an inflammatory reaction and subsequent
fibrosis.2 Fibrosing mediastinitis is also thought to be an
abnormality of collagen production and organization,
akin to idiopathic retroperitoneal fibrosis and on the
spectrum of IgG4-related disease.8 Genetic host factors
may play a role as there is a slight predominance of
women with the disease.4
During this chronic disease process, excess collagen
production entraps mediastinal structures and causes
subsequent symptomatology. Most patients present
with nonspecific symptoms of chest pain, cough and
dyspnea. Only ~20% of patients progress to severe
occlusion of great vessels or airways.5 Obstruction of
pulmonary arteries often results in symptoms of right
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heart failure. Airway obstruction will cause recurrent
episodes of bronchitis or pneumonia in addition to
wheezing, cough and dyspnea. Some patients will have
difficulty swallowing secondary to posterior extension
of the fibrosis entrapping the esophagus.2 The extent
of invasion and obstruction is best visualized with CT
imaging and angiography, although MRI has also been
used.4
There is no known treatment for fibrosing mediastinitis.
No controlled trials of medical or surgical therapy
have been conducted. Antifungal or anti-inflammatory
treatment with corticosteroids is not indicated as this is
a disease primarily of enhanced collagen deposition.5
Placement of intravascular stents has been helpful
in patients with vascular stenosis for symptomatic
management. In one report, percutaneous stenting in
pulmonary arteries or SVC showed effective short-term
and mid-term success in improving vascular patency
of six study patients; however, in-stent re-stenosis
was a frequent complication and progressive fibrosis
remained a clinical problem.7 Thankfully, many patients
have a self-limited course of fibrosis. In a retrospective
study of 80 patients, most patients had a survival similar
to age-matched controls.3
In our patient, her symptomatology can be directly
related to FM. Her lightheadedness on standing is likely
from poor filling pressures of her right atrium from
chronic SVC occlusion. She also has pulmonary vein and
pulmonary artery stenosis, contributing to her dyspnea
and easy fatigability. Her recurrent pneumonias are
also likely explained by airway obstruction. Significant
physical exam finding of large superficial veins are
evidence that her body is compensating for the fibrotic
and obstructive process in her thorax by forming
collateral blood flow. Evidence of collateral blood
flow is also evident in CT imaging showing enlarged
azygous and hemiazygous veins (Figure 3). Her
radiographic imaging strongly points to histoplasmosis
as the etiology of her FM. At the time of this case
report’s authoring, she did not show hemodynamic
compromise requiring intravascular stenting; although,
this is a therapeutic option to consider in the future if
her disease progresses. She is currently being treated
with narcotics and gabapentin for pain control.
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Key Points
In summary, fibrosing mediastinitis is a rare disease and
a rare complication of histoplasmosis. The majority of
adults in the Ohio River Valley have fungal exposure;
however, only a small number of people with prior
Histoplasma infection develop FM. Most patients with
FM have a self-limited course of fibrosis, however some
progress to fatal occlusion of great vessels.
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